UNIVERSAL DISPLAY CORP \PA\ — Investor Relations & Filings
Filings indexed
1,308
across all filing types
Latest filing
2026-03-27
Major Shareholding Noti…
Country
US
United States of America
Listing
US
OLED
Universal Display Corporation is a leader in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials. The company operates as an innovator, patent licensor, and materials supplier for the OLED market. It specializes in inventing and supplying advanced, energy-efficient phosphorescent OLED (PHOLED) materials and technologies. These proprietary components are integral to the manufacturing of high-performance displays for a wide array of consumer electronics, including smartphones, televisions, wearables, and tablets, as well as for solid-state lighting applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Subject) | 2026-03-27 | English | |
| 10-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 8-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | |
| 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 33064229 | SCHEDULE 13G/A - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Subject) | 2026-03-27 | English | ||
| 32885140 | 10-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885139 | 8-K - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885134 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885135 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885136 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885137 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 32885138 | 4 - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer) | 2026-02-19 | English | ||
| 26179944 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 26180234 | 4 Filing | 2026-02-03 | English | ||
| 26180628 | 4 Filing | 2026-01-05 | English | ||
| 26180530 | 4 Filing | 2026-01-05 | English | ||
| 26180327 | 4 Filing | 2026-01-05 | English | ||
| 26180319 | 4 Filing | 2026-01-05 | English | ||
| 26180145 | 4 Filing | 2026-01-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Nautilus Biotechnology, Inc.
Develops a proteome analysis platform to quantify proteins …
|
NAUT | US | Professional, scientific and te… |
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
|
NEUROTECH INTERNATIONAL LIMITED
Clinical-stage biopharmaceutical company developing pediatr…
|
NTI | AU | Professional, scientific and te… |
|
NewAmsterdam Pharma Co N.V.
A clinical-stage biopharma developing therapies for metabol…
|
NAMS | NL | Professional, scientific and te… |
|
NEXALIS THERAPEUTICS LTD
Develops small molecule therapies for chronic inflammatory …
|
NX1 | AU | Professional, scientific and te… |
UNIVERSAL DISPLAY CORP \PA\ via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30834/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30834 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30834 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30834 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30834}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for UNIVERSAL DISPLAY CORP \PA\ (id: 30834)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.